Phenobarbital dyskinesia.

Phenobarbital-induced Gingival Hyperplasia

Phenobarbital: missing in action.

Editorials 871 Epilepsy affects more than 60 million people worldwide, and over 80% of them live in resource-poor countries. 1 Approximately 85% of these people do not receive appropriate treatment 2 because of economic, cultural, social and legislative barriers, compounded by little interest on the part of pharmaceutical companies because drug distribution is not lucrative. Left untreated, peo...

Phenobarbital and Its Sodium Salt

Chem. Abstr. Serv. Reg. No.: 57-30-7 Deleted CAS Reg. Nos: 125-36-0; 8050-96-2 Chem. Abstr. Name: 5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione, monosodium salt IUPAC Systematic Name: 5-Ethyl-5-phenylbarbituric acid, sodium salt Synonyms: 5-Ethyl-5-phenylbarbituric acid sodium; phenobarbital sodium; phenobarbitone sodium; sodium ethylphenylbarbiturate; sodium 5-ethyl-5-phenylbarbiturate; so...

Paroxysmal Kinesigenic Dyskinesia

Background Paroxysmal kinesigenic dyskinesia (PKD) is a rare condition associated with heterozygous mutations in the proline-rich transmembrane protein 2 (PRRT2) gene. Phenomenology Shown In this article we illustrate the phenomenology of PKD in a male previously misdiagnosed with Tourette's syndrome. Educational Value Regardless of the underlying phenotype, PKD is highly responsive to some...

Lingual dyskinesia in hyperthyroidism.

Asirvatham AR, et al. BMJ Case Rep 2017. doi:10.1136/bcr-2017-223226 Description A 28-year-old female presented to the hospital with a 3-month history of palpitation, weight loss and neck swelling. On examination, she had diffuse soft goitre, warm extremities and fine tremors of hands. In addition, she had an irregular jerky lingual and lip movements suggestive of dyskinesia (see online supplem...